By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ISA Pharmaceuticals 

J.H. Oortweg 19

Leiden    NL-2333 CH  The Netherlands
Phone: 31-71-33-22-310 Fax: 31-71-33-22-311



Company News
ISA Pharmaceuticals Release: Towards A Best Practice Approach In Cancer Immunotherapy: Cancer Vaccines Gain Momentum 7/28/2015 9:09:10 AM
ISA Pharmaceuticals Further Strengthens IP Position On Lead Compound ISA101 6/23/2015 8:20:14 AM
New Peer-Reviewed Publication Provides Further Insights Into Mechanism Of ISA Pharmaceuticals’ SLP Immunotherapeutics 5/12/2015 11:13:30 AM
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015 10:40:43 AM
ISA Pharmaceuticals Signs R&D Agreement With Shin Nippon Biomedical Laboratories 3/3/2015 2:31:22 PM
ISA Pharmaceuticals Announces Start Of First Phase 1/2 Clinical Trial Of Its SLP®-AMPLIVANT® Conjugates 2/26/2015 2:50:22 PM
ISA Pharmaceuticals Appoints Hendrik-Jan Laseur As Member Of The Supervisory Board 9/3/2014 10:00:41 AM
ISA Pharmaceuticals Appoints Ronald Loggers As Chief Executive Officer 7/7/2014 9:24:47 AM
ISA Pharmaceuticals Release: New Clinical Data On Cancer Vaccine ISA101 To Be Presented At The American Association for Cancer Research Annual Meeting 2014 3/27/2014 2:23:02 PM
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014 9:39:21 AM